PCSA
Processa Pharmaceuticals, Inc.
+0.10 (+5.41%)1.95USD19.3K成交股數5.4M市值1.9本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 650K | 1.8M | 2.1M | 1.7M | 2.4M | 1.6M | 2.3M | 1.7M | 1.5M | 1.3M | 1.2M | 1.7M |
| 銷售管理費用 | 1.7M | 1.5M | 1.6M | 1.8M | 1.5M | 1.3M | 1.1M | 1.4M | 1.3M | 1.1M | 1.0M | 1.0M |
| 營業利益 | −2.3M-41% | −3.3M+17% | −3.7M+8% | −3.5M+13% | −4.0M+41% | −2.8M+15% | −3.4M+58% | −3.1M+14% | −2.8M | −2.5M | −2.2M | −2.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −3.3M-17% | −3.4M+19% | 23.8M-802% | −3.4M+14% | −3.9M+44% | −2.8M+18% | −3.4M+63% | −3.0M+15% | −2.7M | −2.4M | −2.1M | −2.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -1.19-81% | -1.29-83% | 3.55-445% | -0.07-93% | -6.26+464% | -7.58+416% | -1.03-33% | -1.01-48% | -1.11 | -1.47 | -1.54 | -1.94 |
| 稀釋股數 | 2.8M | 2.6M | 1.3M | 47.5M | 629K | 374K | 3.3M | 3.0M | 2.5M | 1.3M | 1.4M | 1.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 196K | 1.7M | 5.5M | 6.3M | 6.9M | 2.9M | 2.9M | 5.6M | 8.9M | 4.7M | 6.9M | 8.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 2.1M | 4.5M | 7.8M | 7.6M | 8.2M | 4.8M | 4.9M | 7.6M | 9.9M | 5.8M | 8.1M | 10.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 2.4M | 2.0M | 2.2M | 1.8M | 2.1M | 1.3M | 1.2M | 1.6M | 1.1M | 797K | 915K | 931K |
| 股東權益 | −317K | 2.5M | 5.6M | 5.8M | 6.1M | 3.5M | 3.7M | 6.0M | 8.9M | 5.0M | 7.2M | 9.2M |
| 負債比 | 115.3% | 43.8% | 28.6% | 23.1% | 25.4% | 26.7% | 24.7% | 20.8% | 10.7% | 13.8% | 11.3% | 9.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.6M+32% | – | – | – | −2.7M | – | – | −2.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | 13.6M | –% | -10.36 | – |
| FY2024 | – | – | −11.9M | –% | -96.78 | −11.2M |
| FY2023 | – | – | −11.1M | –% | -8.48 | −8.1M |
| FY2022 | 0 | – | −27.4M | –% | -34.05 | – |
| FY2021 | 0 | – | −11.4M | –% | -0.75 | – |
| FY2020 | – | – | −14.4M | –% | -2.54 | – |
| FY2019 | – | – | −3.4M | –% | -0.70 | – |
| FY2018 | – | – | −3.8M | –% | -0.71 | – |